Cells that help to drive the spread of cancer throughout the body can be detected with high sensitivity in early-stage cancer patients using a novel nanomaterial-based chip. The findings, reported online this week in Nature Nanotechnology, suggest that the isolation and recovery of these cells could inform the diagnosis and treatment of cancer patients.
Sunitha Nagrath and colleagues have developed a graphene oxide-based chip that can capture rare circulating tumour cells that detach from the existing tumour and can get carried in the bloodstream to other tissues, thus spreading cancer. Using their nanoscale device, the researchers can select for these cancerous cells from healthy blood cells and analyse them for cancer-related biomarkers. The team believes that these biomarkers will provide insights into the character of the cancer and potentially influence the management of the disease.
Microbiology: Single switch makes Escherichia coli beneficial insect partnerNature Microbiology
Conservation: More than half of unassessable species may be at risk of extinctionCommunications Biology
Zoology: Mother’s iron helps Weddell seal pups diveNature Communications
Health: Certain medications may impact risk of heat-related heart attacksNature Cardiovascular Research